# A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population

> **NCT06724848** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 850 (estimated)

## Conditions studied

- COPD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06724848
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-05
- **Primary completion:** 2027-10-21
- **Final completion:** 2027-10-21
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06724848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06724848, "A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06724848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*